Shanghai Henlius Biotech, Inc. (SGBCF)
Shanghai Henlius Biotech Max Drawdown (5Y)
Max Drawdown (5Y) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Shanghai Haohai Biological Technology Co., Ltd. | -- |
| Ascletis Pharma, Inc. | 99.82% |
| CStone Pharmaceuticals Co. Ltd. | 95.44% |
| RemeGen Co., Ltd. | 90.40% |
| InnoCare Pharma Ltd. | 58.33% |